Respiratory disease inhibitor, preparation method of respiratory disease inhibitor and product immersed with inhibitor

A technology of inhibitor and respiratory tract, applied in the field of products impregnated with inhibitor, can solve the problems of large physical injury, easy recurrence, and ineffective after prolonged use, and achieve the effect of improving energy, inhibiting bacteria and recovering quickly, and promoting rapid recovery.

Inactive Publication Date: 2016-07-13
陈强
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Disadvantages: Bacteria are easy to develop drug resistance, long-term use is ineffective, respiratory tract disease does not develop disease resistance, easy to relapse, and does great harm to the body
In the treatment of traditional Chinese medicine, it is mainly aimed at respirato...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Respiratory disease inhibitor, preparation method of respiratory disease inhibitor and product immersed with inhibitor
  • Respiratory disease inhibitor, preparation method of respiratory disease inhibitor and product immersed with inhibitor

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0019] The preparation method of the respiratory disease inhibitor is as follows: add 2 to 6 parts of ethanol to epoxy resin, heat to 20 to 60°C and stir for 5 to 10 minutes to prepare epoxy resin dilution for later use; add 1 to 5 parts of polythiol Add 0.5-4 parts of ethanol, heat to 20-60°C and stir for 5-10 minutes to prepare polythiol diluent for later use; mix tea tree essential oil, clove essential oil, lavender essential oil and peppermint essential oil, and heat to 20-60°C and stir for 5 - Mix for 10 minutes to make an essential oil mixture.

[0020] Slowly add the remaining amount of polythiol to the essential oil mixture, heat to 20-60°C, stir at a constant temperature at a stirring speed of 2000-5000 rpm for about half an hour; then slowly add epoxy resin diluent to dilute the epoxy resin The time for adding the liquid drops is controlled within 10-30 minutes, heated to a constant temperature of 20-60°C, and at the same time, stirred at a stirring speed (600-2000 r...

Embodiment 1

[0026] The respiratory disease inhibitor comprises the following components in parts by weight: 2 parts of tea tree essential oil, 0.5 part of clove essential oil, 0.4 part of lavender essential oil, 0.6 part of peppermint essential oil, 10 parts of epoxy resin, 55 parts of ethanol and 5 parts of polythiol.

[0027] The preparation method of the respiratory disease inhibitor is as follows: add 2 parts of ethanol to epoxy resin, heat to 25 DEG C and stir for 5 minutes to prepare epoxy resin dilution for later use; add 1 part of ethanol to 1 part of polythiol, heat to Stir at 25°C for 5 minutes to prepare polythiol diluent for later use; mix tea tree essential oil, clove essential oil, lavender essential oil and peppermint essential oil, heat to 20°C and stir for 6 minutes to mix evenly to prepare an essential oil mixture.

[0028] Slowly add the remaining amount of polythiol to the essential oil mixture, heat to 23°C, and stir at a constant temperature of 2500 rpm for 20 minutes...

Embodiment 2

[0032] The respiratory disease inhibitor comprises the following components in parts by weight: 7 parts of tea tree essential oil, 1 part of clove essential oil, 1 part of lavender essential oil, 1 part of peppermint essential oil, 20 parts of epoxy resin, 150 parts of ethanol and 13 parts of polythiol.

[0033] The preparation method of the respiratory disease inhibitor is as follows: add 4 parts of ethanol to epoxy resin, heat to 40 DEG C and stir for 7 minutes to prepare epoxy resin diluent for later use; add 2.5 parts of ethanol to 3 parts of polythiol, heat to Stir at 60°C for 8 minutes to prepare polythiol diluent for later use; mix tea tree essential oil, clove essential oil, lavender essential oil and peppermint essential oil, heat to 40°C and stir for 7 minutes to mix evenly to prepare an essential oil mixture.

[0034] Slowly add the remaining amount of polythiol to the essential oil mixture, heat to 40°C, and stir at a constant temperature of 3500 rpm for half an hou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a respiratory disease inhibitor, a preparation method of the respiratory disease inhibitor and a product immersed with the inhibitor. The respiratory disease inhibitor is prepared from the following components in parts by weight: 2-10 parts of tea tree essential oil, 0.5-3 parts of clove essential oil, 0.4-3.5 parts of lavender essential oil, 0.6-4 parts of peppermint essential oil, 10-30 parts of epoxy resin, 52.5-210 parts of ethanol and 5-18 parts of polymercaptans. The preparation method of the respiratory disease inhibitor comprises the following steps of: preparing an epoxy resin diluent and a polymercaptan diluent for later use; uniformly mixing several essential oils, slowly dropwise adding the polymercaptans, uniformly stirring at constant temperature, slowly adding the epoxy resin diluent, and uniformly stirring at constant temperature to obtain a mixed preparation A; and adding the polymercaptan diluent into the mixed preparation A, uniformly stirring at constant temperature to obtain a mixed preparation B, adding the remained ethanol to dilute the mixed preparation B, and uniformly stirring at constant temperature to obtain a finished product inhibitor.

Description

technical field [0001] The invention relates to a respiratory disease inhibitor, a preparation method thereof and a product impregnated with the inhibitor. Background technique [0002] At present, when treating respiratory diseases, western medicine and traditional Chinese medicine are mainly used for treatment. In western medicine treatment, antibiotics are mainly used as the main drug, which enters the blood circulation in the form of medicine or infusion to inhibit the growth of bacteria and achieve the purpose of rapid relief of pain. Disadvantages: Bacteria are easy to develop drug resistance, long-term use is ineffective, the respiratory disease does not develop disease resistance, easy to relapse, and does great harm to the body. Traditional Chinese medicine treatment mainly targets respiratory diseases caused by lung heat. Therefore, traditional Chinese medicine treatment mainly focuses on clearing heat and cooling blood. The disadvantage is that it can only achieve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/61A61K47/34A61P11/00A61P31/12A61P31/02D06M13/00D06M15/55D06M15/63
CPCA61K36/61A61K36/53A61K36/534A61K47/10D06M13/00D06M15/55D06M15/63A61K2300/00
Inventor 陈强
Owner 陈强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap